Acorah Software Products - Accounts Production 16.8.200 false true 31 March 2025 1 April 2024 false true No description of principal activity 1 April 2025 31 March 2026 31 March 2026 SC542492 Hasan Rashid iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC542492 2025-03-31 SC542492 2026-03-31 SC542492 2025-04-01 2026-03-31 SC542492 frs-core:CurrentFinancialInstruments 2026-03-31 SC542492 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 SC542492 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 SC542492 frs-bus:Micro-entities 2025-04-01 2026-03-31 SC542492 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 SC542492 frs-bus:Director1 2025-04-01 2026-03-31 SC542492 2024-03-31 SC542492 2025-03-31 SC542492 2024-04-01 2025-03-31 SC542492 frs-core:CurrentFinancialInstruments 2025-03-31
Registered number: SC542492
HRG Pharma Limited
Unaudited Financial Statements
For The Year Ended 31 March 2026
Balance Sheet
Registered number: SC542492
2026 2025
£ £
Fixed assets 199 249
Current assets 100,667 86,993
Creditors: Amounts Falling Due Within One Year (43,468 ) (40,701 )
NET CURRENT ASSETS 57,199 46,292
TOTAL ASSETS LESS CURRENT LIABILITIES 57,398 46,541
NET ASSETS 57,398 46,541
CAPITAL AND RESERVES 57,398 46,541

Notes

1. General Information
HRG Pharma Limited is a private company, limited by shares, incorporated in Scotland, registered number SC542492 . The registered office is 15 Kyle Drive, Giffnock, Glasgow, G46 6ES.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Hasan Rashid
Director
27/04/2026